Cancer Chemoprevention: Volume 2: Strategies for Cancer Chemoprevention (Cancer Drug Discovery and Development) - Image 1

£34.58

Humana Cancer Chemoprevention: Volume 2: Strategies for Cancer Chemoprevention (Cancer Drug Discovery and Development)

Name: Cancer Chemoprevention: Volume 2: Strategies for Cancer Chemoprevention (Cancer Drug Discovery and Development)
Brand: Humana
Price: 34.58 GBP
Availability: InStock

Oncology

Price History & Forecast

Last 1 days • 1 data points (No recent data available)

Historical

Generating forecast...

Not enough data points to display chart (need at least 2 points)

Price Distribution

Price distribution over 1 days • 1 price levels

Days at Price

Price Analysis

Most common price: £35 (1 days, 100.0%)

Price range: £35 - £35

Price levels: 1 different prices over 1 days

Description

Despite significant advances in cancer treatment and measures of neoplastic progression, drug effect (or early detection, overall cancer incidence has increased, pharmacodynamic markers), and markers that measure cancer-associated morbidity is considerable, and overall prognosis as well as predict responses to specific therapy. cancer survival has remained relatively flat over the past All these biomarkers have the potential to greatly augment several decades (1,2). However, new technology the development of successful chemoprevention therapies, allowing exploration of signal transduction pathways, but two specific types of biomarkers will have the most identification of cancer-associated genes, and imaging of immediate impact on successful chemopreventive drug tissue architecture and molecular and cellular function is development―those that measure the risk of developing increasing our understanding of carcinogenesis and cancer invasive life-threatening disease, and those whose mo- progression. This knowledge is moving the focus of cancer lation can “reasonably predict” clinical benefit and, therapeutics, including cancer preventive treatments, to therefore, serve as surrogate endpoints for later-occurring drugs that take advantage of cellular control mechanisms clinical disease. Thus far, the biomarker that best measures to selectively suppress cancer progression. these two phenomena is intraepithelial neoplasia (IEN) Carcinogenesis is now visualized as a multifocal, because it is a near obligate precursor to cancer.

Product Specifications

Brand: Humana
Format: Hardcover
ASIN: 1588290778
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 01 February 2005
Listed Since: 05 February 2007

Barcode

No barcode data available

Humana Cancer Chemoprevention: Volume 2: Strategies for Cancer Chemoprevention (Cancer Drug Discovery and Development)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Cancer Chemoprevention: Volume 2: Strategies for Cancer Chemoprevention (Cancer Drug Discovery and Development)

Trends in Cancer Prevention Research

Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis

Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis

Prevention of Cancer: New Research

Research Progress in Cancer Prevention

Chemical Carcinogenesis (Current Cancer Research)

Phytopharmaceuticals in Cancer Chemoprevention: 2 (CRC Series in Modern Nutrition Science)

Chemistry and Pharmacology of Anticancer Drugs

CRC Press - Chemistry and Pharmacology of Anticancer Drugs

Cancer Prevention: Dietary Factors and Pharmacology (Methods in Pharmacology and Toxicology)

Cancer Chemoprevention: Volume 1: Promising Cancer Chemopreventive Agents (Cancer Drug Discovery and Development)

Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

Cancer Chemotherapy: Basic Science to the Clinic

Chemical Carcinogenesis (Current Cancer Research)

Molecular Biomarkers for Cancer Diagnosis and Therapy

Checkpoint Responses in Cancer Therapy (Cancer Drug Discovery and Development)

Cancer Proteomics: From Bench to Bedside (Cancer Drug Discovery and Development)

Cancer Diagnostics: Current and Future Trends (Contemporary Cancer Research)

Cancer Drug Resistance (Cancer Drug Discovery and Development)

Biomarkers in Breast Cancer (Cancer Drug Discovery and Development)

IntechOpen Carcinogenesis - Molecular and Cellular Processes

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)